With regard to its suppression of macrophage hyperactivation, it is interesting to understand whether Mint3 inhibitors are available for modulating the cytokine storm in the coronavirus disease (COVID-19)53,54 and other chronic inflammatory diseases, such as rheumatoid arthritis and type-2 diabetes. The gene discussed is APBA3; the disease is type 2 diabetes mellitus.